APA
LUMO

American Portfolios Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

American Portfolios Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$11.1K Hold
1,250
– – ﹤0.01% 2490
2022
Q2 		$9.63K Hold
1,250
– – ﹤0.01% 2587
2022
Q1 		$11.8K Hold
1,250
– – ﹤0.01% 2621
2021
Q4 		$8.66K Buy
+1,250
New +$10.5K ﹤0.01% 2682

Other funds holding LUMO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 28.88% 1-Year Est. Return

American Portfolios Advisors's LUMO Position: Q3 2022 in Review

American Portfolios Advisors held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q3 2022 at 1,250 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

American Portfolios Advisors first reported a position in LUMO in Q4 2021 and has held it in 4 quarters since. The position peaked at $11.8K in Q1 2022. 35 funds tracked by Wall St. Rank hold LUMO as of Q3 2022.

  • American Portfolios Advisors held 1,250 shares of Lumos Pharma, Inc. Common Stock worth $11.1K as of Q3 2022.
  • American Portfolios Advisors left its Lumos Pharma, Inc. Common Stock share count unchanged in Q3 2022.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2490 holding.
  • American Portfolios Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2021 and has held it in 4 quarters since.
  • American Portfolios Advisors's Lumos Pharma, Inc. Common Stock position peaked at $11.8K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.